ArticleCancer immunology, immunotherapy : CII2016

A phase I study of recombinant (r) vaccinia-CEA(6D)-TRICOM and rFowlpox-CEA(6D)-TRICOM vaccines with GM-CSF and IFN-α-2b in patients with CEA-expressing carcinomas.

Megan C Duggan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.